Interview with Dr. Christian Reinhard at UEGW 2016 about the first 18 months of market experience with IBDoc®

 

Interview with Dr. Christian Reinhard at UEGW 2016 about the first 18 months of market experience with IBDoc®

At this year’s UEGW in Vienna, Dr. Christian Reinhard presented data collected from the first 18 months of market experience with IBDoc®. In the biomarker session on Tuesday 18th of October the IBDoc® product manager at BÜHLMANN Laboratories AG
presented an overview of the published data and including some new and unpublished data from a study with 58 patients. The study was focused on a comparison of the new calprotectin home test with the laboratory gold standard BÜHLMANN fCAL® ELISA. In this method comparison a total within target agreement of 80% was reached. After the oral presentation we recorded an interview covering the most recent data and the outlook for calprotectin home testing.

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video


Have a look at the orignial YouTube Video on the BÜHLMANN YouTube channel.